Search research articles
Contact Us
Filters
Showing results (611-620 of 633) with videos related to
Page
of 64
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2022
First-in-human phase I study of TQ-B3139 (CT-711) in advanced non-small cell lung cancer patients with ALK and ROS1 rearrangements
Yuxiang Ma, Hongyun Zhao, Jinhui Xue, et al.
Med (New York, N.Y.)
|
February 1, 2025
Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trial
Liang Zeng, Huan Yan, Wenjuan Jiang, et al.
Cancer Immunology, Immunotherapy : CII
|
March 7, 2024
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China
Huan Yan, Lianxi Song, Yizhi Li, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 25, 2024
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective study
Zhe Huang, Yuda Zhang, Qinqin Xu, et al.
Cancer Letters
|
January 12, 2025
RET-AREAL: A multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIs
Xinjun Tang, Jie Hu, Renhua Guo, et al.
Plos One
|
September 2, 2015
Prion Protein Protects against Renal Ischemia/Reperfusion Injury
Bo Zhang, Daniel Cowden, Fan Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 16, 2025
NHWD-870 suppresses tumor proliferation via the BRD4/STRADA/CCND1 axis in small cell lung cancer
Linrui Ma, Xiangyu Zhang, Shidong Xu, et al.
Nature Medicine
|
February 2, 2026
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
Zhe Huang, Liang Zeng, Zhaohui Ruan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 2, 2025
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancer
Liang Zeng, Fan Tong, Xingxiang Xu, et al.
Cell Discovery
|
September 8, 2021
RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates
Xiaoyan Pan, Jian Shi, Xue Hu, et al.
Page
of 64
Search research articles
Search
Showing results (611-620 of 633) with videos related to
Sort By:
Page
of 64
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2022
First-in-human phase I study of TQ-B3139 (CT-711) in advanced non-small cell lung cancer patients with ALK and ROS1 rearrangements
Yuxiang Ma, Hongyun Zhao, Jinhui Xue, et al.
Med (New York, N.Y.)
|
February 1, 2025
Toripalimab plus platinum-doublet chemotherapy as perioperative therapy for initially unresectable NSCLC: An open-label, phase 2 trial
Liang Zeng, Huan Yan, Wenjuan Jiang, et al.
Cancer Immunology, Immunotherapy : CII
|
March 7, 2024
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China
Huan Yan, Lianxi Song, Yizhi Li, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 25, 2024
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective study
Zhe Huang, Yuda Zhang, Qinqin Xu, et al.
Cancer Letters
|
January 12, 2025
RET-AREAL: A multi-center, real-world data analysis on the efficacy of pralsetinib in acquired RET fusion after resistance to EGFR/ALK-TKIs
Xinjun Tang, Jie Hu, Renhua Guo, et al.
Plos One
|
September 2, 2015
Prion Protein Protects against Renal Ischemia/Reperfusion Injury
Bo Zhang, Daniel Cowden, Fan Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 16, 2025
NHWD-870 suppresses tumor proliferation via the BRD4/STRADA/CCND1 axis in small cell lung cancer
Linrui Ma, Xiangyu Zhang, Shidong Xu, et al.
Nature Medicine
|
February 2, 2026
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
Zhe Huang, Liang Zeng, Zhaohui Ruan, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 2, 2025
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancer
Liang Zeng, Fan Tong, Xingxiang Xu, et al.
Cell Discovery
|
September 8, 2021
RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates
Xiaoyan Pan, Jian Shi, Xue Hu, et al.
Page
of 64